Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

References for PMC Articles for PubMed (Select 21343564)

1.

Semi-supervised recursively partitioned mixture models for identifying cancer subtypes.

Koestler DC, Marsit CJ, Christensen BC, Karagas MR, Bueno R, Sugarbaker DJ, Kelsey KT, Houseman EA.

Bioinformatics. 2010 Oct 15;26(20):2578-85. doi: 10.1093/bioinformatics/btq470. Epub 2010 Aug 16.

2.

Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells.

Ouyang W, Beckett O, Ma Q, Paik JH, DePinho RA, Li MO.

Nat Immunol. 2010 Jul;11(7):618-27. doi: 10.1038/ni.1884. Epub 2010 May 13.

PMID:
20467422
3.

Methylation markers for small cell lung cancer in peripheral blood leukocyte DNA.

Wang L, Aakre JA, Jiang R, Marks RS, Wu Y, Chen J, Thibodeau SN, Pankratz VS, Yang P.

J Thorac Oncol. 2010 Jun;5(6):778-85. doi: 10.1097/JTO.0b013e3181d6e0b3.

4.

Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer.

Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Weisenberger DJ, Shen H, Campan M, Noushmehr H, Bell CG, Maxwell AP, Savage DA, Mueller-Holzner E, Marth C, Kocjan G, Gayther SA, Jones A, Beck S, Wagner W, Laird PW, Jacobs IJ, Widschwendter M.

Genome Res. 2010 Apr;20(4):440-6. doi: 10.1101/gr.103606.109. Epub 2010 Mar 10.

5.

An epigenetic signature in peripheral blood predicts active ovarian cancer.

Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Gayther SA, Apostolidou S, Jones A, Lechner M, Beck S, Jacobs IJ, Widschwendter M.

PLoS One. 2009 Dec 18;4(12):e8274. doi: 10.1371/journal.pone.0008274.

6.

Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications.

Wu X, Hildebrandt MA, Chang DW.

Cancer Metastasis Rev. 2009 Dec;28(3-4):269-80. doi: 10.1007/s10555-009-9190-y. Review.

PMID:
20016998
7.

Lymphocytes in cancer development: polarization towards pro-tumor immunity.

Ruffell B, DeNardo DG, Affara NI, Coussens LM.

Cytokine Growth Factor Rev. 2010 Feb;21(1):3-10. doi: 10.1016/j.cytogfr.2009.11.002. Epub 2009 Dec 11. Review.

8.

Glucocorticoid therapy and risk of bladder cancer.

Dietrich K, Schned A, Fortuny J, Heaney J, Marsit C, Kelsey KT, Karagas MR.

Br J Cancer. 2009 Oct 20;101(8):1316-20. doi: 10.1038/sj.bjc.6605314. Epub 2009 Sep 22.

9.

Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context.

Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Padbury JF, Bueno R, Sugarbaker DJ, Yeh RF, Wiencke JK, Kelsey KT.

PLoS Genet. 2009 Aug;5(8):e1000602. doi: 10.1371/journal.pgen.1000602. Epub 2009 Aug 14.

10.

Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer.

Wu X, Ye Y, Kiemeney LA, Sulem P, Rafnar T, Matullo G, Seminara D, Yoshida T, Saeki N, Andrew AS, Dinney CP, Czerniak B, Zhang ZF, Kiltie AE, Bishop DT, Vineis P, Porru S, Buntinx F, Kellen E, Zeegers MP, Kumar R, Rudnai P, Gurzau E, Koppova K, Mayordomo JI, Sanchez M, Saez B, Lindblom A, de Verdier P, Steineck G, Mills GB, Schned A, Guarrera S, Polidoro S, Chang SC, Lin J, Chang DW, Hale KS, Majewski T, Grossman HB, Thorlacius S, Thorsteinsdottir U, Aben KK, Witjes JA, Stefansson K, Amos CI, Karagas MR, Gu J.

Nat Genet. 2009 Sep;41(9):991-5. doi: 10.1038/ng.421. Epub 2009 Aug 2. Erratum in: Nat Genet. 2009 Oct;41(10):1156. Guarrera, Simonetta [added]; Polidoro, Silvia [added].

11.

Genome-wide association studies in bladder cancer: first results and potential relevance.

Kiemeney LA, Grotenhuis AJ, Vermeulen SH, Wu X.

Curr Opin Urol. 2009 Sep;19(5):540-6. doi: 10.1097/MOU.0b013e32832eb336. Review.

PMID:
19553824
12.

Common vs. rare allele hypotheses for complex diseases.

Schork NJ, Murray SS, Frazer KA, Topol EJ.

Curr Opin Genet Dev. 2009 Jun;19(3):212-9. doi: 10.1016/j.gde.2009.04.010. Epub 2009 May 28. Review.

13.

Cancer statistics, 2009.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ.

CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.

14.

Selenium and risk of bladder cancer: a population-based case-control study.

Wallace K, Kelsey KT, Schned A, Morris JS, Andrew AS, Karagas MR.

Cancer Prev Res (Phila). 2009 Jan;2(1):70-3. doi: 10.1158/1940-6207.CAPR-08-0046.

15.

The global burden of urinary bladder cancer.

Parkin DM.

Scand J Urol Nephrol Suppl. 2008 Sep;(218):12-20. Review.

PMID:
19054893
16.

Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions.

Houseman EA, Christensen BC, Yeh RF, Marsit CJ, Karagas MR, Wrensch M, Nelson HH, Wiemels J, Zheng S, Wiencke JK, Kelsey KT.

BMC Bioinformatics. 2008 Sep 9;9:365. doi: 10.1186/1471-2105-9-365.

17.

Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study.

Widschwendter M, Apostolidou S, Raum E, Rothenbacher D, Fiegl H, Menon U, Stegmaier C, Jacobs IJ, Brenner H.

PLoS One. 2008 Jul 16;3(7):e2656. doi: 10.1371/journal.pone.0002656.

18.

Familial and genetic risk of transitional cell carcinoma of the urinary tract.

Mueller CM, Caporaso N, Greene MH.

Urol Oncol. 2008 Sep-Oct;26(5):451-64. doi: 10.1016/j.urolonc.2008.02.016. Epub 2008 Jun 18. Review.

19.

Projecting individualized probabilities of developing bladder cancer in white individuals.

Wu X, Lin J, Grossman HB, Huang M, Gu J, Etzel CJ, Amos CI, Dinney CP, Spitz MR.

J Clin Oncol. 2007 Nov 1;25(31):4974-81.

20.

Regulatory T cells and cancer.

Wang HY, Wang RF.

Curr Opin Immunol. 2007 Apr;19(2):217-23. Epub 2007 Feb 15. Review.

PMID:
17306521
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk